USAM yields 20000.00% · PFE yields 6.13%● Live data
📍 USAM pulled ahead of the other in Year 1
Combined, USAM + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of USAM + PFE for your $10,000?
U.S. Automotive Manufacturing, Inc. manufactures new and rebuilt automotive friction products. The company's line of friction automotive products include brake lining, integrally molded and riveted brake pads, and remanufactured brake shoes. Brake pads, brake shoes or a combination of both are incorporated in all makes and models of American and imported automobiles. It markets various grades of friction lining, asbestos, non-asbestos organic, and semi-metallic formulas, suitable for use by the automotive and light truck after-markets. It generally produces the replacement brakes under the same process used to manufacture the vehicle's original equipment. The company sells its products to wholesale and retail automotive distributors, mass merchandisers, chain stores, and to other brake manufacturers in the United States and in 11 foreign countries. U.S. Automotive Manufacturing, Inc. was founded in 1992 and is based in Sanford, Florida.
Full USAM Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.